MFS
BMRN icon

Mirabella Financial Services’s BioMarin Pharmaceuticals BMRN Stock Holding History

Mirabella Financial Services’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,043
Closed -$597K – 935
2025
Q4 		$597K Buy
+10,043
New +$547K 0.06% 207
2024
Q3 		– Sell
-2,487
Closed -$205K – 198
2024
Q2 		$205K Buy
+2,487
New +$207K 0.01% 393
2023
Q2 		– Sell
-25,652
Closed -$1.33M – 499
2023
Q1 		$1.33M Sell
25,652
-8,232
-24% -$853K 0.22% 94
2022
Q4 		$3.51M Buy
33,884
+30,940
+1,051% +$2.9M 0.31% 57
2022
Q3 		$250K Sell
2,944
-3,416
-54% -$304K 0.03% 249
2022
Q2 		$527K Buy
+6,360
New +$506K 0.05% 238
2021
Q1 		– Sell
-5,257
Closed -$461K – 290
2020
Q4 		$461K Buy
+5,257
New +$417K 0.06% 177

Other funds holding BMRN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return